guanfacine
NDC 0228-2850, guanfacine, tablet, extended release, from Actavis Pharma, Inc..
- Product NDC
- 0228-2850
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200881
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0228-2850 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUANFACINE HYDROCHLORIDE1 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0228-2850-11 | 00228285011 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2850-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3a171942-37af-430d-8b9d-bb678ca2be4bNADAC price for package 00228285011
GET /v1/drugs/nadac/00228285011
Use it
Look up 0228-2850 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0228-2850 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0228-2850. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.